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A B S T R A C T
Introduction: Airway epithelial cells have been described to release extracellular vesicles (EVs) with pathological
properties when exposed to cigarette smoke extract (CSE). As CSE causes oxidative stress, we investigated
whether its oxidative components are responsible for inducing EV release and whether this could be prevented
using the thiol antioxidants N-acetyl-L-cysteine (NAC) or glutathione (GSH).
Methods: BEAS-2B cells were exposed for 24 h to CSE, H2O2, acrolein, 5,5′-dithiobis-(2-nitrobenzoic acid)
(DTNB), bacitracin, rutin or the anti-protein disulfide isomerase (PDI) antibody clone RL90; with or without NAC
or GSH. EVs in media were measured using CD63+CD81+ bead-coupled flow cytometry or tunable resistive
pulse sensing (TRPS). For characterization by Western Blotting, cryo-transmission electron microscopy and
TRPS, EVs were isolated using ultracentrifugation. Glutathione disulfide and GSH in cells were assessed by a GSH
reductase cycling assay, and exofacial thiols using Flow cytometry.
Results: CSE augmented the release of the EV subtype exosomes, which could be prevented by scavenging thiol-
reactive components using NAC or GSH. Among thiol-reactive CSE components, H2O2 had no effect on exosome
release, whereas acrolein imitated the NAC-reversible exosome induction. The exosome induction by CSE and
acrolein was paralleled by depletion of cell surface thiols. Membrane impermeable thiol blocking agents, but not
specific inhibitors of the exofacially located thiol-dependent enzyme PDI, stimulated exosome release.
Summary/conclusion: Thiol-reactive compounds like acrolein account for CSE-induced exosome release by
reacting with cell surface thiols. As acrolein is produced endogenously during inflammation, it may influence
exosome release not only in smokers, but also in ex-smokers with chronic obstructive pulmonary disease. NAC
and GSH prevent acrolein- and CSE-induced exosome release, which may contribute to the clinical benefits of
NAC treatment.
1. Introduction
Situated at the vast interface between environment and lung tissue,
the airway epithelium is crucial for maintaining pulmonary home-
ostasis. Not only does it act as a physical barrier, it also supports
appropriate responses to inhaled pathogens and chemicals by sending
signals towards immune and stromal cells in its vicinity (for a review,
see [1]). Yet, epithelial integrity and function become impaired upon
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chronic exposure to noxious stimuli, for instance in long term cigarette
smokers [2]. Cigarette smoke-induced epithelial damage is partly
mediated by components that cause oxidative stress, such as the
reactive oxygen species (ROS) hydrogen peroxide (H2O2) [3,4] and
the reactive carbonyl acrolein [5,6]. The oxidative stress exerted by
cigarette smoke components is thought to contribute to the early
pathogenesis of chronic obstructive pulmonary disease (COPD) [7].
Moreover, once COPD is established, markers of oxidative stress, as well
as acrolein, remain elevated in the lungs even after patients stop
smoking [8,9]. Recent studies have revealed that treatment with a high-
dose of the thiol-group bearing mucolytic and antioxidant N-acetyl-L-
cysteine (NAC) improved small airway function in COPD patients [10]
and lowered the frequency of acute exacerbations [11]. This suggests
that oxidative stress causally contributes to small airway disease and
worsening of COPD via acute exacerbations, even in ex-smokers.
A number of studies have suggested that oxidative stress influences
the release of extracellular vesicles (EVs) by various cell types [12–14].
EVs are membrane vesicles secreted by nearly all cell types. They
consist of a lipid bilayer surrounding an aqueous lumen, and act as
carriers for molecules derived from their cell of origin, including
membrane proteins, cytoplasmic proteins and RNA. EV functions
include removing unnecessary or toxic molecules from their cell of
origin [15,16], as well as delivering complex messages between cells
[17]. Thus, EVs regulate many biological processes, including immune
responses and inflammation [17]. Although EV nomenclature is com-
plex and still controversial [18], EVs are commonly classified into two
major groups based on their size and marker expression, the larger
microvesicles and the smaller exosomes. In the context of cigarette
smoke-induced lung disease, microvesicles have been studied predomi-
nantly to evaluate their utility as biomarkers for early lung damage and
exacerbation susceptibility [19,20]. In contrast, the smaller exosomes
have been investigated for functional properties that may contribute to
COPD pathogenesis. Two recent in vitro studies have suggested that
exosomes secreted by airway epithelial cells (AEC) exposed to cigarette
smoke extract (CSE) cause inflammation [21] and tissue remodeling by
inhibiting fibroblast autophagy [22]. Yet, it has not been clarified how
CSE influences the exosome release by AEC and whether this can be
manipulated. We hypothesized that oxidative CSE components, such as
H2O2 or acrolein, mediate CSE-induced exosome release and that the
exosome induction can be prevented by antioxidants.
2. Materials and methods
2.1. Cell culture
BEAS-2B human bronchial epithelial cells (ATCC CRL-9609) were
cultured at 5% CO2 and 37⁰C in T-75 culture flasks pre-coated with LHC
basal medium (Gibco, Life Technologies, New York, NY, USA) supple-
mented with 0.1 mg/ml bovine serum albumin (BSA, Boehringer
Mannheim GmbH, Mannheim, Germany), 0.03 mg/ml bovine collagen
I (BD Biosciences, San Jose, CA, USA) and 0.01 mg/ml human
fibronectin (BD Biosciences). Cells were subcultured twice per week
in RPMI1640 (Gibco) containing 10% fetal calf serum (FCS, Lonza,
Verviers, Belgium).
2.2. EV-depletion of FCS
To deplete confounding bovine EVs, FCS was diluted to 30% (v/v)
in DMEM-F12 without phenol-red (Gibco) and centrifuged for 16 h at
40,000 rpm (Average RCF =117,734×g), in a fixed-angle Type 70Ti-
rotor in an Optima L-90K preparative ultracentrifuge (Beckman-
Coulter, Brea, CA, USA). The supernatant was collected without
disturbing the concentrated layer at the bottom of the tube.
2.3. Stimuli and cell exposures
N-acetyl-L-cysteine (NAC), H2O2, acrolein, 5,5′-dithiobis-(2-nitro-
benzoic acid) (DTNB), bacitracin and rutin were from Sigma Aldrich
(St. Louis, MO, USA). The monoclonal anti-protein disulfide isomerase
(PDI) antibody clone RL90 was from Thermo Fisher Scientific
(Waltham, MA, USA). To produce CSE, mainstream smoke of one
cigarette (Reference Cigarette 3R4F, Tobacco-Health Research,
University of Kentucky, USA) without filter was drawn through 2 ml
phosphate buffered saline (PBS) using a vacuum-pump at constant
speed. The obtained solution was filtered through a 0.22 µm Acrodisk
filter (Pall, Port Washington, NY, USA) and defined as 100% CSE. For
quality control, the extinction of 100 µl 100% CSE was measured in
duplicate at wavelengths of λ=320 nm (A320) and λ=540 nm (A540).
CSE quality was accepted if ΔOD (A320-A540) was between 0.9 and
1.2. CSE was prepared freshly for each experiment and used within
15 min.
BEAS-2B cells were seeded in RPMI1640+10% (v/v) FCS on pre-
coated plates (5×104 cells/cm2) and allowed to attach for 24 h. Cells
were washed twice with PBS and incubated with reduction medium
(DMEM-F12+0.1% (v/v) EV-depleted FCS, 0.25 ml/cm2) for 2 h. Next,
cells were exposed to different concentrations of CSE, acrolein, H2O2,
DTNB, bacitracin, rutin or RL90 in reduction medium for 24 h. Where
indicated, cells were treated with NAC (1 mM) or GSH (62.5, 125 or
250 µM) for 2 h. After these 2 h, cells were washed with PBS to remove
any pre-formed EVs. Then, NAC or GSH were added again to the cells in
combination with either CSE, acrolein or H2O2 and co-incubated for
24 h. Rutin was dissolved in DMSO, all other chemicals were dissolved
and diluted in PBS. Vehicle controls were exposed to matched
concentrations of DMSO or PBS. The vehicle control for RL90 contained
0.0005% (v/v) sodium azide.
2.4. MTT assay
Cells were washed with PBS and 200 µl/cm2 reduction medium
containing 0.5 mg/ml thiazolyl blue tetrazolium bromide (MTT; Sigma
Aldrich) was added. After 3 h, medium was discarded and the formed
formazan crystals were dissolved in 100 µl/cm2 dimethyl sulfoxide
(DMSO; Sigma Aldrich). Absorbance of the dissolved formazan was
measured at λ=540 nm and cell viability was expressed relative to a
non-treated cells (100% cell viability) and triton-lysed cells (0%
viability).
2.5. GSH measurements
For determining GSH oxidation in cell-free conditions, different CSE
dilutions were made in PBS containing 50 µM reduced glutathione
(Sigma Aldrich) and incubated for 24 h at 37⁰C. Ten microliter of each
solution was transferred to a 96-well plate in triplicate. Ninety
microliter of DTNB working reagent (1 mM DTNB and 2.5 mM sodium
acetate in 0.1 M Tris-hydrochloride, pH 8.8) was then added.
Absorbance was measured with a plate reader at λ=412 nm.
For analyzing cellular GSH concentrations, 2×105 cells were
washed twice with ice cold PBS. They were then incubated on ice with
250 µl 0.1 M potassium phosphate buffer containing 5 mM ethylene-
diaminetetraacetic acid (EDTA) disodium salt and 0.1% (v/v) Triton X-
100, pH =7.5 for 30 min. Next, cells were scraped and cellular debris
was pelleted at 16,100×g at 4 °C for 15 min. Supernatant was
transferred to a new tube. Protein concentrations were determined
using the Bradford assay according to the manufacturer's protocol (Bio-
Rad, Hercules, CA, USA). The remaining supernatant was mixed 1:1
with 6% (m/v) sulfosalicylic acid. The samples were stored at −80 °C
until analysis of GSH and the GSH oxidation product glutathione
disulfide (GSSG) using an enzymatic cycling assay as previously
described [23]. GSSG and GSH concentrations were normalized to the
protein concentrations.
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2.6. Quantification of exofacial thiol groups
Cells (2×105) were washed 3× with PBS and incubated for 10 min
with 2 mM EDTA in PBS before gentle scraping. Detached cells were
pelleted at 400×g for 7 min at 4 °C and resuspended in PBS. Alexa
Fluor® 488 C5 Maleimide (AFM; Thermo Fisher Scientific, Waltham,
MA, USA) was added to the homogenous cell suspension to a final
concentration of 2.5 µM, followed by 15 min incubation on ice. Cells
were pelleted again (400×g, 7 min, 4 °C), washed with PBS, followed
by a last centrifugation (400×g, 7 min, 4 °C). For flow cytometry
measurements using a BD FACSCanto and FACS Diva V8.0.1 software
(BD Biosciences), cells were resuspended in PBS containing 1% (w/v)
bovine serum albumin (BSA; Sigma Aldrich). Just before measuring,
1 µg/ml propidium iodide (PI; Sigma Aldrich) was added in order to
gate out cells with impaired membrane integrity. The relative quantity
of exofacial thiol groups was determined as the median fluorescence
intensity of AFM in the PI-low cell population.
2.7. Processing conditioned cell culture medium
Conditioned medium of BEAS-2B cells (1 ml per condition for EV
measurements using bead-coupled flow cytometry, 40 ml for EV isola-
tion using ultracentrifugation) was centrifuged at 300×g for 10 min at
4 °C to pellet cells, then at 5000×g for 10 min at 4 °C to pellet cell
debris. Where indicated, the conditioned medium was filtered through
a 0.22 µm filter to remove larger membrane vesicles. Conditioned
medium was always processed within one day without any freeze-thaw
cycles.
2.8. Analysis of EV release using bead-coupled flow cytometry
EV detection using bead-coupled flow cytometry was performed as
described previously [24,25], with some adaptations: 3.5×108 beads/
ml (4 µM aldehyde/sulfate latex beads 5% (w/v); Molecular Probes Life
Technologies, Waltham, MA, USA) were coated with 0.125 mg/ml
mouse anti-human CD63 antibody (Clone H5C6; BD Biosciences) by
overnight incubation in MES buffer. These beads were stored in PBS
containing 0.1% (m/v) glycine and 0.1% (m/v) sodium azide at 4⁰C
until use. For EV-coupling, 2×105 CD63-coated beads were incubated
with 400 µl conditioned medium overnight. Beads were then washed
twice with PBS containing 2% (m/v) BSA by centrifugation at 5000×g
for 10 min. The bead pellet was resuspended in 50 µl PBS-2% (m/v)
BSA containing 0.01 mg/ml phycoerythrin (PE)-labeled mouse anti-
human CD81 antibody (Clone JS-81; BD Biosciences) and incubated for
1 h. Beads were washed twice with PBS – 2% (m/v) BSA by centrifuga-
tion at 5000×g for 10 min. The final bead pellet was resuspended in
200 µl PBS and analyzed by flow cytometry using a BD FACSCanto (BD
Biosciences) with FACS Diva V8.0.1 software (BD Biosciences). All
incubations were carried out at room temperature and with vigorous
shaking (1000 min−1). The quantity of EVs in relative fluorescent units
(RFU) was calculated by multiplying the percentage of PE-positive
beads with the median fluorescent intensity (MFI) of the positive bead
population.
2.9. EV analysis using tunable resistive pulse sensing (TRPS)
TRPS was performed using a qNano Gold with Izon Control Suite 3.2
Software and CPC100 calibration beads (Izon, Chirstchurch, New
Zealand). Cell-depleted unfiltered medium was analyzed after a single
freeze-thaw cycle at −80 °C. An NP150 nanopore (Izon) was coated
using the Izon reagent kit for EV analysis according to the manufac-
turer's instructions. To obtain a stable baseline current, samples were
diluted 1:2 in Solution Q (Izon) and to prevent frequent pore obstruc-
tion, 10% (v/v) Solution G (Izon) was added. The NP150 nanopore was
used at a stretch of 45–47 mm and a pressure of 10–12 mbar, keeping
the current between 120 and 130 nA for all measurements. Recordings
were stopped after detection of 500 blockades or after 10 min.
2.10. EV isolation using ultracentrifugation
Cell-depleted medium (40 ml/condition) was filtered through an
Acrodisk 0.22 µm filter (Pall) to remove larger membrane vesicles or
particles. The filtered medium was centrifuged in an Optima L-90K
preparative ultracentrifuge (Beckman-Coulter) using a fixed-angle Type
70Ti-rotor (Beckman-Coulter) and QuickSeal tubes (Ultra-Clear, 39 ml,
Beckman-Coulter) at 40,000 rpm (Average RCF =117,734×g) for 2.5 h
(optimal speed and duration as determined by Cvjetkovic et al. [26]).
After ultracentrifugation, supernatant was poured off and the invisible
EV-pellet was resuspended in 70 µl PBS for cryo-TEM, 70 µl lysis buffer
(1.5% (m/v) sodium dodecyl sulfate (SDS), 50 mM Tris, pH =6.8) for
Western blotting, or in 2.5 ml DMEM-F12+0.1% (v/v) EV-depleted FCS
for flow cytometric analysis. For cyro-TEM and flow cytometric
analysis, isolated EVs were processed immediately. For Western blot-
ting, samples were stored in lysis buffer at −80 °C until gel electro-
phoresis was performed.
2.11. Western blotting
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) was performed according to standard protocol, with a 12%
running gel. Before loading, the protein concentration of all cell and EV
lysates was standardized and samples were diluted 1:2 in 2 x XT sample
buffer (Bio-Rad) containing 5 M urea and cOmplete™ protease inhibitor
cocktail (Roche Life Science, Penzberg, Germany) at the concentration
recommended by the manufacturer. Blots were stained for 2–3 h with
0.5 µg/ml mouse anti-human CD63 antibody (Clone H5C6; BD
Biosciences), followed by 1 h incubation with HRP-conjugated rabbit
anti-mouse antibody diluted 1:1000 (P0260; DAKO, Agilent
Technologies, Santa Clara, CA, USA). The blots were incubated with
chemiluminescent peroxidase substrate-3 (Sigma Aldrich) and signal
was detected using an enhanced chemiluminescence system
(ChemiDoc™ MP System, Bio-Rad).
2.12. Cryo-transmission electron microscopy
To prepare vitrified EV specimens, a freshly glow-discharged
Quantifoil R 2/2 grid (Quantifoil Micro Tools GmbH, Jena, Germany)
was loaded into a FEI Mark IV Vitrobot (FEI Company, Eindhoven, The
Netherlands). The Vitrobot environmental chamber was maintained at
22 °C and 100% humidity. Three microliter of freshly isolated EV
suspension was added to the grid. The grid was blotted immediately for
1 s before plunge-freezing in liquid ethane (−180 °C). For microscopy,
grids were mounted in a Gatan cryoholder (Gatan, Pleasanton, CA,
USA) in liquid nitrogen and images were acquired at 120 kV using a
Tecnai Biotwin iCorr 120KV (FEI Company).
2.13. Statistics
All data are composed of at least three independent experiments.
Data were analyzed with Graphpad Prism software (GraphPad
Software, Inc., La Jolla, CA, USA). Because of the small sample size
and the paired nature of the data, data was analyzed using the non-
parametric Wilcoxon matched-pairs signed rank test (where 2 groups
were compared) or the non-parametric Friedman test, followed by
Dunn's posthoc test (where more than 2 groups were compared) unless
indicated differently. P-values below 0.05 were considered statistically
significant. Values in the text are given as the median and interquartile
range (IQR).
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3. Results
3.1. CSE exposure enhances the release of EVs with exosome properties by
AEC
To determine the effect of CSE-exposure on EV release by AEC,
BEAS-2B cells were exposed to CSE concentrations ranging from 0.75%
to 1.5% (v/v) for 24 h. The quantity of CD63+CD81+ EVs in the
conditioned media was assessed using bead-coupled flow cytometry. A
concentration-dependent increase in EV release was observed from 1.4
fold (IQR 1.3–1.6) at 0.75% CSE up to 2.3 fold (IQR 1.6–2.7) at 1.5%
CSE (Fig. 1A). This was associated with a decrease in cell viability
ranging from 88.0% (IQR 79.6–97.6) cell viability at 0.75% CSE to
52.7% (IQR 46.5–63.5) at 1.5% CSE (Fig. 1B). Using TRPS, we
confirmed an increased concentration of small EVs (80–250 nm in
diameter) after 24 h exposure to 1.5% (v/v) CSE (Fig. 1C, D). The EV
induction was fast and sustained, as the EV concentration was increased
for CSE-exposed cells at 30 min, 3 h and 24 h (Fig. 1E). Moreover, the
induction required the continuous presence of CSE, as there was no
increased EV concentration compared to the unexposed control when
cells were stimulated with CSE for 3 h, followed by washing and 24 h
incubation in CSE-free medium (Fig. 1E).
The tetraspanins CD63 and CD81, which we used for flow cyto-
metric EV detection, are classically considered specific marker proteins
for the smallest EV type, exosomes [27]. However, it has recently been
suggested that the larger microvesicles may express these proteins as
well [28]. To determine whether the EVs detected by CD63+CD81+
flow cytometry were truly exosomes, we first determined their size by
comparing the flow cytometry signal in non-filtered media with the
signal in media passed through a 0.22 µm filter. Signal recovery after
filtration was complete for both control and CSE-induced EVs (Fig. 2A),
suggesting that the vast majority of EVs detected using bead-coupled
flow cytometry was smaller than 220 nm. We also determined the size
distribution of EVs in unfiltered conditioned media using TRPS. The
mode size was about 100 nm for both, control EVs and CSE EVs, with
the majority of particles being smaller than 200 nm (Fig. 1C). One of
Fig. 1. Effect of CSE-exposure on EV release and cell viability of BEAS-2B cells. (A) EV concentrations (CD63+CD81+ bead-coupled flow cytometry) after 24 h exposure to 0.75–1.5% (v/
v) CSE, n =4. (B) Cell viability (MTT assay) after 24 h exposure to 0.75–1.5% (v/v) CSE, n =4. (C) TRPS size distribution histogram of EVs released by BEAS-2B cells exposed for 24 h
exposure to 0 or 1.5% (v/v) CSE. Bars represent the mean± standard error of the mean (SEM), n =6. The vertical dotted lines at 80 and 250 nm indicate the size limits between which EV
concentration was determined for Fig. 1D. (D) Concentration of EVs ranging from 80 to 250 nm (size range indicated by vertical dotted lines in Fig. 1C) as determined by TRPS after
exposing BEAS-2B cells for 24 h exposure to 0 or 1.5% (v/v) CSE, n =6. (E) EV concentrations in media of BEAS-2B cells exposed to CSE for 30 min, 3 h or 24 h, or exposed to CSE for 3 h
followed by 24 h incubation in CSE-free medium. Box and whisker plots (A-B,D-E) indicate the median (line in box), 25th and 75th percentiles (outer lines of box) and the minimal and
maximal values (whiskers). Statistical differences were analyzed using Friedmann's test with Dunn's posthoc test in Figs. A and B and using Wilcoxon matched-pairs signed rank test in
figure D (*p< 0.05 compared with 0% CSE).
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the most commonly applied isolation protocols for small EVs is 0.22 µm
filtration of conditioned cell culture medium followed by ultracentri-
fugation at high speed (e.g. 120,000×g). Using this protocol, a large
fraction of CD63+CD81+ EVs measured in the conditioned medium
could be recovered both for control EVs (63.4%, IQR 33.4–80.9%) and
CSE-induced EVs (39.3%, IQR 17.7–105.4%) (Fig. 2C). Western blotting
confirmed the presence of CD63 in the ultracentrifugation isolate from
both exposure conditions, whereas the endoplasmic reticulum-derived
contamination marker grp94 was undetectable (Fig. 2D). Finally, cryo-
TEM of isolated control EVs and CSE EVs revealed membrane
surrounded spheres ranging from 30 to 170 nm in diameter (Fig. 2E,
F). Based on the properties described in this paragraph, we will from
now on refer to the EVs in this study as exosomes.
3.2. The exosome induction is mediated by CSE components that react with
thiol groups and is prevented by clinically relevant concentrations of thiol-
antioxidants
To confirm that CSE contains oxidative components, CSE was
incubated with the thiol group bearing antioxidant GSH. This resulted
in a concentration-dependent depletion of free GSH (data not shown).
Next, to investigate whether the oxidative components of CSE were
causally responsible for the exosome induction, AEC were exposed to
CSE in the absence or presence of the antioxidant NAC. NAC completely
prevented CSE-induced exosome release as determined by
CD63+CD81+ bead-coupled flow cytometry (Fig. 3A) and by TRPS
(Fig. 3B). It also prevented the decrease in cell viability (Fig. 3C).
Clinically, NAC is used in COPD patients as a mucolytic and
antioxidant. While oral NAC treatment hardly increases NAC concen-
trations in the lung, it has been reported to result in a 1.7-fold increased
GSH concentration in the epithelial lining fluid of patients with
idiopathic pulmonary fibrosis, from 190 µM to 320 µM [29]. To
determine whether CSE-induced EV release can be inhibited by such
clinically relevant GSH concentrations, BEAS-2B cells were exposed to
CSE in the continuous presence of different GSH concentrations. GSH
concentration-dependently prevented EV induction by CSE (Fig. 4A)
and restored cell viability (Fig. 4B). EV inhibition reached statistical
significance at 125 µM GSH and was complete for 250 µM GSH.
Among all CSE components, ROS such as H2O2 and reactive
carbonyls such as acrolein can react with the thiol groups of both,
GSH and NAC [30]. To determine whether these components contribute
to CSE-induced exosome release, we exposed BEAS-2B cells for 24 h to
either H2O2 or acrolein and measured the same parameters as after CSE
exposure. H2O2 did not affect exosome release (Fig. 5A) at concentra-
tions resulting in similar decreases in cell viability to CSE (Fig. 5B). In
Fig. 2. Characterization of EVs released by BEAS-2B cells after 24 h exposure to 0 or 1%
(v/v) CSE. (A) Quantity of EVs detected using bead-coupled flow cytometry for
CD63+CD81+ EVs in conditioned medium before and after 0.22 µm-filtration; n =7.
(B) Recovery of EVs by ultracentrifugation, estimated using bead-coupled flow cytometry
for CD63+CD81+ EVs; n =5. (C) Western blots of EVs isolated by ultracentrifugation.
Blots were stained for endoplasmic reticulum-derived contamination marker grp94 and
exosome marker CD63. (D) Cryo-TEM of EVs. The scale bars are 100 nm. (E) EV diameter
according to cryo-TEM (horizontal bars indicate the median; n =18 for control EVs and n
=17 for CSE EVs). Statistical differences in EV diameter were analyzed using the Mann-
Whitney test (N.S. = not significant). Box and whisker plots (A-B) indicate the median
(line in box), 25th and 75th percentiles (outer lines of box) and the minimal and maximal
values (whiskers).
Fig. 3. Contribution of oxidative components to the effects of CSE on EV release and cell
viability. BEAS-2B cells were exposed to 1.5% (v/v) PBS (control) or 1.5% (v/v) CSE for
24 h in the continuous presence of the thiol-group bearing antioxidant NAC. (A) Effect of
NAC on CSE-induced EV release (CD63+CD81+ bead-coupled flow cytometry), n =6. (B)
Effect of NAC on CSE-induced EV release (TRPS), n =6. (C) Effect of NAC on cell viability
(MTT assay), n =6. All graphs show the median± IQR. Statistical differences were
analyzed using Friedmann's test with Dunn's posthoc test (*p< 0.05). Box and whisker
plots indicate the median (line in box), 25th and 75th percentiles (outer lines of box) and
the minimal and maximal values (whiskers).
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contrast, acrolein augmented exosome release (Fig. 5C) already at
concentrations that only mildly affected cell viability (Fig. 5D). Similar
to the CSE-induced exosome release, the exosome induction by acrolein
was completely prevented in the continuous presence of NAC (Fig. 5E)
and cell viability was restored (Fig. 5F). This suggests that CSE and
acrolein have a different effect on cellular thiols than H2O2, and that
this difference may account for the EV induction.
3.3. Reaction with exofacial thiols is sufficient to enhance EV release
We next aimed to identify changes in cellular thiols that may
mediate the exosome induction by CSE and acrolein. First, the
intracellular concentrations of reduced GSH and its oxidation product
GSSG were measured. While 24 h exposure to CSE or acrolein caused an
increase in both, reduced GSH (Supplementary Fig. 1A, B) and its
disulfide GSSG (Supplementary Fig. 1D, E), the increase in GSH was
stronger as illustrated by an increasing GSH/GSSG ratio (Fig. 6A, B).
Upon H2O2 exposure, GSH only increased slightly (Supplementary
Fig. 1C), while GSSG (Supplementary Fig. 1F) and the GSH/GSSG ratio
(Fig. 6C) remained unchanged. Next, the quantity of free thiol groups
on the cell surface was assessed using the membrane impermeable thiol
dye AFM. At concentrations of the three stimuli that were re-matched
for their effect on cell viability, CSE and acrolein both lead to a
concentration-dependent depletion of exofacial thiol groups (Fig. 6D,
E), while H2O2 showed no effect (Fig. 6F). Thus, the oxidative stress
caused by 24 h exposure to CSE or acrolein was compensated at the
intracellular level, as illustrated by the increased GSH/GSSG ratio, but
not on the cell surface, as illustrated by the depleted exofacial thiol
groups. Finally, cells were exposed to CSE for 3 h, followed by 24 h
incubation in CSE-free medium, which does not result in increased EV
release compared to unexposed cells (Fig. 1E). While GSH
(Supplementary Fig. 1G), GSSG (Supplementary Fig. 1H), and the
GSH/GSSG ratio (Fig. 7A) were increased similarly as during 24 h
exposure to CSE, there was no effect on the exofacial thiol groups
(Fig. 7B). Therefore, the EV induction is more likely mediated by the
depletion of exofacial thiols than by the intracellular GSH response.
We next assessed whether depletion of exofacial thiol groups is
sufficient to enhance EV release. For this purpose, we exposed the
BEAS-2B cells to either DTNB or bacitracin for 24 h. Both compounds
have poor membrane permeability and block exofacial thiol groups by
forming disulfide bonds [31–34]. Both, DTNB and bacitracin, induced
EV release (Fig. 7A) without affecting cell viability (Fig. 7B). Bacitracin
is known to inhibit the reductase function of protein disulfide isomerase
(PDI). However, PDI is not the only target of bacitracin [35]. For this
reason, PDI reductase activity was inhibited more specifically using
rutin [36] or the monoclonal anti-PDI antibody clone RL90. However,
no effect on EV release was observed for either rutin or the PDI specific
antibody at concentrations that have previously been shown to inhibit
PDI activity [36,37] and that were non-cytotoxic (Fig. 7A, B).
4. Discussion
Cigarette smoke causes serious damage to the airway epithelium
[38,39] and, in long term smokers, it forms an important risk for
developing COPD [40]. In vitro, AEC exposed to CSE have been reported
to release exosomes which induce myofibroblast differentiation [22]
and cytokine secretion [21] in cells that have not been in direct contact
with CSE. Therefore, it is conceivable that cigarette smoke-induced
exosomes are involved in the pathogenesis of COPD. Understanding the
biochemical mechanisms by which cigarette smoke influences exosome
release by AEC, and how this can be prevented, could therefore be of
clinical relevance.
The first objective of this study was to characterize the EV release
after exposure of AEC to CSE in terms of quantity and EV properties.
Using CD63+CD81+-bead coupled flow cytometry and the label-free
TRPS technique, we found that CSE exposure enhances EV release
concentration- and time-dependently. Based on their size and marker
expression we classified both, control EVs and CSE-induced EVs, as
exosomes. Our highly specific methods corroborate and extend a report
from Moon et al. who found that CSE exposure of AEC increases the
protein content of a 100,000×g ultracentrifugation pellet [21], which
can be seen as a rough estimate for exosome quantity. Notably, we
found that the increased exosome release upon CSE-exposure was
paralleled by a concentration- and time-dependent decrease in cell
viability. Yet, it is unlikely that cell death causes the increase in
exosomes irrespective of the stimulus, since exposure to H2O2-concen-
trations with a similar impact on cell viability did not enhance exosome
release. Additionally, the thiol-blocking compounds DTNB and baci-
tracin both enhanced EV release without affecting cell viability.
Our second objective was to identify the chemical trigger for CSE-
induced exosome release. In line with previous research, we found that
CSE is thiol-reactive as it depletes the free thiol groups of GSH in a
direct reaction. Moreover, scavenging thiol-reactive compounds in CSE
using the thiol-antioxidants NAC or GSH completely prevented the
exosome induction. This implies that thiol-reactive compounds within
CSE entirely account for the increased exosome release. Components of
Fig. 4. Effect of 24 h co-incubation with several GSH concentrations on CSE-induced EV release and cytotoxicity in BEAS-2B cells. (A) EV release (CD63+CD81+ bead-coupled flow
cytometry; n=5). (B) Cell viability (MTT assay; n=5). The unstimulated control was set to 100% in both graphs. Box and whisker plots indicate the median (line in box), 25th and 75th
percentiles (outer lines of box) and the minimal and maximal values (whiskers). Statistical analysis was performed using Friedmann's test with Dunn's posthoc test (* p< 0.05 compared
to 1.5% (v/v) CSE/0 µM GSH).
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CSE that can react with thiol groups and thus can be neutralized by
thiol-antioxidants comprise ROS such as H2O2, which cause disulfide
bond formation [41,42]; and thiol-reactive carbonyls such as acrolein
[43], which form adducts [44]. In our study, the cellular effects of CSE
could not be mimicked by H2O2. Although the used H2O2 concentra-
tions caused a similar decrease in cell viability to CSE, they had no
effect on exosome release. This is in contrast to the findings of Hedlund
et al. who have shown that lymphoma cells release more CD63+ EVs
when exposed to H2O2 for 24 h [13]. Therefore, it may be cell-type
specific whether an oxidative stimulus like H2O2 induces exosome
release or not.
In contrast to H2O2, acrolein mimicked all cellular effects observed
for CSE, including NAC-reversible induction of exosome release. Based
on data from Lambert et al., who quantified acrolein in CSE, we
estimate that the CSE concentration in our experiments (1.5% (v/v))
contains between 2.6 and 37.5 µM acrolein [45]. This corresponds well
with our experimental acrolein concentrations of 12.5–15 µM. More-
over, the fold-change increase in exosome release was similar after
Fig. 5. Effect of H2O2 and acrolein on EV release and cell viability. BEAS-2B cells were exposed for 24 h to H2O2 (A-B) or, alternatively, acrolein in the absence or continuous presence of
NAC (C-F). EV release was determined using CD63+CD81+ bead-coupled flow cytometry. Cell viability was assessed using MTT assay. (A) Effect of H2O2 on EV release, n =4. (B) Effect
of H2O2 on cell viability, n =4. (C) Effect of acrolein on EV release, n =4. (D) Effect of acrolein on cell viability, n =4. (E) Effect of NAC on acrolein-induced EV release (n =4). (F) Effect
of NAC on acrolein-induced cytotoxicity (n =4). Box and whisker plots indicate the median (line in box), 25th and 75th percentiles (outer lines of box) and the minimal and maximal
values (whiskers). Statistical differences were determined using the Friedmann's test with Dunn's posthoc test (*p< 0.05 compared to unexposed control (B-D) or p< 0.05 for 15 µM
acrolein /1 mM NAC compared to 15 µM acrolein /0 mM NAC (E)).
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exposure to 1.5% (v/v) CSE and 15 µM acrolein (2.2± 0.3 fold vs.
1.9± 0.3 fold). In addition, NAC could completely restore exosome
concentrations to the control level for both, CSE and acrolein exposure.
Therefore, it is conceivable that acrolein accounts for the exosome
induction upon CSE exposure. Intriguingly, acrolein and other thiol-
reactive carbonyls are not only present in CSE, but are also formed
endogenously during inflammation and oxidative stress [46,47]. Thiol-
reactive carbonyls have been shown to be increased in COPD patients
who have stopped smoking [9], and in other conditions characterized
by inflammation and oxidative stress, such as diabetes and neuroin-
flammatory disorders [48–51]. Hence, they may serve as triggers for
exosome release in these chronic inflammatory disorders. This is
especially interesting as exosomes have been shown to play a patholo-
gical role in both, metabolic and neuroinflammatory diseases [52,53].
Moreover, NAC, which can prevent thiol-reactive carbonyl-induced
exosome release has not only been attributed a protective role in COPD,
but also in metabolic and neurological disorders [54,55].
Thirdly, we aimed to identify the cellular target that mediates the
EV induction by CSE. Therefore, we first assessed how free thiol
concentrations were affected at different subcellular locations.
Intracellularly, 24 h exposure to CSE and acrolein, but not to H2O2,
led to an overall increase in free thiols as indicated by an increased
GSH/GSSG ratio. Such an upregulation of the endogenous antioxidant
response has previously been reported for cells exposed to reactive
carbonyls [5,56]. In spite of the excess of the oxidant-scavenging GSH
inside the cell, free thiol groups on the cell surface were still depleted
after 24 h. This suggests the cellular target that mediates the EV
induction by CSE may be located on the cell surface. Indeed, blocking
exofacial thiols using either of two membrane-impermeable com-
pounds, DTNB or bacitracin, was sufficient to induce exosome release
with a similar fold-change to CSE. One target of bacitracin is cell
surface-associated PDI [34,35]. Notably, PDI has previously been
implied in EV release [37] and a recent study reports that CSE and
acrolein, but not H2O2, inhibit PDI reductase activity [57]. However, in
this study neither of two specific PDI reductase inhibitors, i.e. the
flavonoid rutin [36] and the monoclonal antibody RL90 [37,58],
elicited an increased exosome release. Thus, blocking thiol-disulfide
exchange reactions on the cell surface may be the mechanism by which
CSE enhances exosome release, but the precise molecular target
remains to be elucidated. It is conceivable that exofacial thiol-depletion
causes secondary intracellular changes, which then result in the
exosome induction. However, we expect that the depletion of exofacial
thiols directly results in the exosome induction as the induction already
occurs within 30 min of exposure and requires the continuous presence
of the stimulus. CSE may trigger the membrane fusion required for
exosome release, as thiol-dependent mechanisms have long been known
to regulate membrane fusion [59].
As CSE-induced exosomes have been attributed potentially detri-
mental functions [21,22], the ultimate objective of this study was also
to evaluate whether exosome induction could be prevented by anti-
oxidants at clinically relevant concentrations. Recent meta-analyses
encourage the use of NAC in COPD patients, as high doses (≥1200 mg/
day orally) were found to be well tolerated and efficient in decreasing
exacerbation frequency [11,60] and to improve small airway function
[10]. As the bioavailability of the unchanged NAC molecule is low, the
beneficial effects are attributed to NAC serving as a precursor for GSH
Fig. 6. BEAS-2B cells were exposed to CSE, acrolein or H2O2 for 24 h. The intracellular GSH/GSSG ratio was determined by means of a GSH reductase cycling assay (A-C) and exofacial
free thiol groups were detected using AFM (D-F). (A) The intracellular GSH/GSSG ratio after 24 h exposure to CSE, n =6. (B) The intracellular GSH/GSSG ratio after 24 h exposure to
acrolein, n =5. (C) The intracellular GSH/GSSG ratio after 24 h exposure to H2O2, n =6. (D) Exofacial thiols detected by AFM after 24 h exposure to CSE, n =4. (E) Exofacial thiols
detected by AFM after 24 h exposure to acrolein, n =4. (F) Exofacial thiols detected after 24 h exposure to H2O2, n =4. Box and whisker plots (A-F) indicate the median (line in box), 25th
and 75th percentiles (outer lines of box) and the minimal and maximal values (whiskers). Statistical differences were determined using the Friedmann's test with Dunn's posthoc test
(*p< 0.05 compared to unexposed control).
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[61]. GSH concentrations are severely decreased in the epithelial lining
fluid (ELF) of COPD patients compared to healthy controls [61]. While
it is not known if GSH in ELF of COPD patients can be restored by NAC
treatment, patients with idiopathic pulmonary fibrosis have similarly
decreased GSH concentrations (190 µM vs. 380 µM in the control
group) and these are restored to the normal level (310 µM) by high
dose NAC (1800 mg/day orally) [29]. Here, we found that GSH
prevents CSE-induced EV release at 125–250 µM, which matches the
concentration range observed in the IPF study. Thus, future studies
should aim to explore whether inhibition of exosome release contri-
butes to the protective outcome of oral NAC treatment in COPD
patients.
A limitation of this study is that exposure to CSE in vitro is acute,
whereas it is chronic cigarette smoking that forms the major risk factor
for developing COPD. Additionally, it is currently impossible to match
the in vitro CSE exposure to the in vivo CS exposure of the epithelium of
smokers. However, it has been argued that acute CSE exposure in vitro is
suitable to model changes in the naïve lung during the earliest phase of
COPD development [62]. Nevertheless, to translate the in vitro findings
of our study, it would be revealing to investigate exosome concentra-
tions in bronchoalveolar lavage fluid or plasma of smokers and COPD
patients compared with non-smoking control subjects. Although we did
not address functional properties of CSE-induced exosomes, there is
evidence from earlier studies that CSE-induced airway epithelial-
derived exosomes are involved in the pathogenesis of COPD by
inducing of pro-inflammatory cytokines and profibrotic changes
[21,22]. Therefore, it should also be studied whether exosomes from
patients’ body fluids contribute to the pathogenesis of COPD.
5. Conclusion
Our study reveals that CSE exposure enhances the exosome release
by AEC. This is mediated by thiol-reactive compounds like the carbonyl
acrolein, which may act by depleting extracellular free thiols. Thiol-
antioxidants like NAC and GSH inhibit exosome release induced by CSE
or acrolein, which may contribute to the therapeutic benefits of NAC in
COPD. These findings pave the way for future research investigating the
role of cigarette smoke- and reactive carbonyl-induced exosomes in the
pathogenesis of COPD and other chronic inflammatory diseases.
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